Genincode【GENI】銘柄情報

Genincode Plc (GENI) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.875

( -2.78% )

買値

0.85

売値

0.90

出来高

5,825,781

平均取引量 (3 か月)

6,696,876p

財務取引量

53,708p

0.875 日の範囲 0.95

0.825 52 週間の範囲 5.25

時価総額

6.589M

企業価値

6.096M

前日終値

0.90

始値

0.90

時刻

500000

0.85

(O)

最終取引時間

VWAP

0.9219

歳入

3.08M

純利益

-5.71M

発行済株式数

753,041,137

浮動株比率 (%)

49.44%

機関投資家保有比率 (%)

59.60%

配当利回り

PER

-0.43

株価売上高倍率 (PSR)

2.2

1 株当たり利益 (EPS)

-0.02

ベータ

0.59

GENinCode Plc engages in the development and commercialization of clinical genetic tests for predictive analysis of risk to a patient’s health based on genes in the United Kingdom, Spain, Italy, the United States, Germany, and internationally. The company offers CARDIO inCode Score, a genetic test t... GENinCode Plc engages in the development and commercialization of clinical genetic tests for predictive analysis of risk to a patient’s health based on genes in the United Kingdom, Spain, Italy, the United States, Germany, and internationally. The company offers CARDIO inCode Score, a genetic test to evaluate the risk of coronary heart disease; LIPID inCode, a genetic test for the diagnosis of familial hypercholesterolemia with further coronary risk stratification of the patient; and SUDD inCode, a genetic diagnostic test for familial heart diseases, such as cardiomyopathies, channelopathies, and aortopathies related with sudden cardiac death syndrome. It also provides THROMBO inCode, a genetic test for the diagnosis of hereditary thrombophilia and for assessing the patient's risk of thrombosis; THROMBO inCode reproductive health, a genetic test that evaluates the impact of hereditary thrombophilia in patients with repeated miscarriages; and risk of ovarian cancer algorithm test product. In addition, the company is involved in Medical and scientific research activities. GENinCode Plc was incorporated in 2018 and is based in Manchester, the United Kingdom. 詳細を表示

セクター

Healthcare

業界

Medical Diagnostics & Screening

ウェブサイト

www.genincode.com

本社

Manchester, United Kingdom

設立

2026

Genincode Plc is listed in the Healthcare sector of the ロンドン証券取引所 with ticker GENI. The last closing price for Genincode was 0.90p. Over the last year, Genincode shares have traded in a share price range of 0.825p to 5.25p.

Genincode currently has 753,041,137 shares in issue. The market capitalisation of Genincode is £6.59 million. Genincode has a price to earnings ratio (PE ratio) of -0.43.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.075	-7.89473684211	0.95	0.958	0.875	1779388	0.91006749	DE
4	-0.125	-12.5	1	1.075	0.825	3755646	0.91769317	DE
12	-0.475	-35.1851851852	1.35	1.375	0.825	6280916	1.08741579	DE
26	-1.325	-60.2272727273	2.2	2.2	0.825	5721391	1.12506649	DE
52	-1.125	-56.25	2	5.25	0.825	3291906	1.43218504	DE
156	-10.875	-92.5531914894	11.75	13.5	0.825	1281501	1.89516789	DE
260	-47.625	-98.1958762887	48.5	48.5	0.825	818748	2.87679189	DE